Report cover image

Subcutaneous Drug Delivery Market

Publisher Coherent Market Insights
Published May 18, 2023
Length 178 Pages
SKU # CMI18001213

Description

Subcutaneous Drug Delivery Market, By Usability (Disposable, and Reusable), By Disease Indication(Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy & Infectious Disorders, Ophthalmic Disorders, and Others, By Delivery System(Prefilled Syringes, Autoinjector, Pen Injectors, Disposable, and others)By Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer, German manufacturer of primary packaging introduced metal-free Lure Lock Gx RTF Syringe in June 2020, without tungsten to create the perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal.

Moreover, in March 2022, YpsoMed, medical device companies developed YpsoMate SmartPilot, a reusable attachment to its proprietary YpsoMate pen, which is designed for an easy two-step injection process. The device has a sensor and memory, which is connected to an app, which displays injection timing and doses. The pen provides audio and visual feedback to users. The app can also remind users when it is time to inject the insulin.

Market Dynamics

Product approvals by regulatory authorities is expected to drive the market growth over the forecast period. For instance, on March 6, 2023, Coherus BioSciences, Inc, its global biosimilar company, announced U.S. Food and Drug Administration (FDA) approved a single-dose, prefilled auto injector presentation of UDENYCA (pegfilgrastim-cbqv). The UDENYCA autoinjector has a streamlined, easy-to-use design for use in both in-office and at-home settings of care.

Key features of the study:
  • This report provides in-depth analysis of the global subcutaneous drug delivery market and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global subcutaneous drug delivery market based on the following parameters–company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Inc., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, Merck & Co., Inc., Insulet Corporation, West Pharmaceutical Services, Inc Gerresheimer AG and other prominent key players.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • Global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market
Detailed Segmentation:
  • Global Subcutaneous Drug Delivery Market, Usability
Disposable

Reusable
  • Global Subcutaneous Drug Delivery Market, Disease Indication
Auto-immune Disorders

Neurological Disorders

Oncology Disorders

Hormonal Disorders

Allergy & Infectious Disorders

Ophthalmic Disorders

Others
  • Global Subcutaneous Drug Delivery Market, Delivery System
Prefilled Syringes

Autoinjector
  • Spring Type
  • Motorized Type
  • Wearable Type
Pen Injectors
  • Disposable
  • Reusable
  • Syringes (Injector)
Others (pump, etc.)
  • Global Subcutaneous Drug Delivery Market, By Distribution Channel
Hospital Pharmacies

Retail Pharmacies

Online Pharmacies
  • Global Subcutaneous Drug Delivery Market, By Region:
North America
  • By Country:
U.S.

Canada

Latin America
  • By Country:
Brazil

Mexico

Argentina

Rest of Latin America

Europe
  • By Country:
Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific
  • By Country
China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East
  • By Country:
GCC Countries

Israel

Rest of Middle East

Africa
  • By Country/Region:
South Africa

Central Africa

North Africa
  • Company Profiles
Becton Dickinson and Company,
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
Novo Nordisk A/S,

Johnson & Johnson

Novartis International AG

Amgen, Inc.

Teva Pharmaceutical Industries Ltd.

F. Hoffmann-La Roche AG.,

Consort Medical plc,

Eli Lilly and Company

Merck & Co., Inc.

Insulet Corporation,

West Pharmaceutical Services, Inc.

Gerresheimer AG

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

178 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Usability
Market Snapshot, By Disease Indication
Market Snapshot, By Delivery System
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Merger, Acquisition, and Collaborations
Product Launch
Regulatory Scenario
PEST Analysis
4. Global Subcutaneous Drug Delivery Market- Impact of Coronavirus (Covid-19) Pandemic
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Subcutaneous Drug Delivery Market, By Usability, 2017–2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Disposable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Reusable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
6. Global Subcutaneous Drug Delivery Market, By Disease Indication , 2017-2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Auto-immune Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Neurological Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Oncology Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Hormonal Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Allergy & Infectious Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Ophthalmic Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
7. Global Subcutaneous Drug Delivery Market, By Delivery System, 2017-2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Prefilled Syringes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Auto injector
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Pen Injectors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Disposable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Others (pump, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
8. Global Subcutaneous Drug Delivery Market, By Distribution Channel, 2017-2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
9. Global Subcutaneous Drug Delivery Market, By Region, 2017–2030, (US$ Billion)
Overview
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Region, 2017–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017– 2030, (US$ Billion)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017– 2030, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017– 2030, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017– 2030, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017– 2030, (US$ Billion)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017– 2030, (US$ Billion)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profiles
Becton Dickinson and Company
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Novo Nordisk A/S
Johnson & Johnson.
Novartis International AG
Amgen, Inc
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche AG.
Consort Medical plc.
LaVision Biotec GmbH
Eli Lilly and Company
Merck & Co., Inc.
Insulet Corporation
West Pharmaceutical Services, Inc.
Gerresheimer AG.
11. Section
References
Research Methodology
About us and Sales Contact
*Browse 22 market data tables and 18 figures on “Global Subcutaneous Drug Delivery Market”- Global forecast to 2030.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us